Major Research Areas
Molecular Pharmacology & Chemistry
Keep up-to-date on all the latest news about the Tan Lab here!

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 ]



05/12/2008  Working at the Hospital: Challenging and rewarding careers in chemistry await at research hospitals and medical centers (Chemical & Engineering News)

For many chemists, the traditional career path begins with a job in industry or a position leading to a tenure-track spot in an academic department. But synthetic, medicinal, and organic chemists are increasingly carving out rewarding careers at research hospitals and medical centers. [Full text]

11/01/2007  An Interview with Derek Tan (MSKCC Center News)

To understand biology, scientists often use the power of chemistry. As the head of a laboratory in the Molecular Pharmacology and Chemistry Program at the Sloan-Kettering Institute, Derek Tan is a young leader in the field of chemical biology. [Full text]

07/01/2007  28th Annual Memorial Sloan-Kettering Convocation Ceremony: Graduates and award winners celebrated (MSKCC Center News)

Justin [Potuzak's] research focused on a class of molecule called spiroketals that are found in a variety of biologically natural products. He developed a brand-new approach to synthesizing these molecules and in the process discovered a truly novel chemical reaction. His molecules are now being tested against a wide range of biological targets. [Full text]

02/20/2007  2007 Sloan Research Fellowships Announced (Alfred P. Sloan Foundation)

09/01/2006  27th Annual Convocation Ceremony (MSKCC Center News)

Sirkka Moilanen was awarded a Frank L. Horsfall, Jr. Fellowship for 2006-2007. [Full text]

05/30/2006  2006 Convocation Awards for Weill Graduate School of Medical Sciences (Weill Cornell News Dean's Bulletin)

Justin Potuzak was awarded a 2006 Vincent du Vigneaud Prize for his work on the stereocontrolled synthesis of spiroketals using novel kinetic cyclization reactions. [Full text]

05/17/2006  Chemical Biology Initiative Symposium 2006: Frontiers of Drug Discovery: Chemical Library Development and Screening (University of Minnesota)

The ability to design chemical probes capable of modulating and altering biological processes in highly defined ways is essential to carrying out modern biomedical and pharmaceutical research. The aim of this workshop was to inform biomedical, pharmacological, medicinal, computational and chemical researchers at the University of Minnesota of recent advances in chemical library design and screening with the goal of fostering multidisciplinary research projects harnessing these techniques. [Full text]

02/02/2006  Chemistry: Order of the rings (Nature)

One of the great challenges in organic chemistry is developing novel ways to synthesize complex structures. The best reactions work for a range of chemical substrates, and give high yields. By these criteria, a reaction, discovered by Derek Tan of the Memorial Sloan-Kettering Cancer Center in New York and his co-workers is near ideal. [Full text]

06/13/2005  Investigadores elaboran compuesto para combatir bacterias de la tuberculosis y la peste negra (Mercosur Económico)

Investigadores de dos prestigiosas instituciones de Nueva York…desarrollaron un compuesto capaz de combatir bacterias -de la tuberculosis y de la peste negra- y permitir la elaboración de nuevas drogas contra una enfermedad que afecta a un tercio de la población mundial -la tuberculosis- y otra en condiciones de ser empleada como arma biológica en bioterrorismo -la peste negra-. [Full text (PDF)]

05/30/2005  A New Way To Fight Bacteria: Inhibitor blocks biosynthesis of key bacterial iron-scavenging agent (Chemical & Engineering News)

A novel strategy for fighting bacterial infections has been demonstrated: blocking bacterial biosynthesis of siderophores, compounds that make it possible for certain bacteria to obtain iron, which they require to grow and to cause disease. [Full text]

05/26/2005  Chemical Biology: Ironing out bugs (Nature)

Researchers from Cornell University and the Memorial Sloan-Kettering Cancer Center in New York have devised a molecule that binds to and inhibits enzymes involved in siderophore synthesis. The compound successfully reduces the growth of both Mycobacterium tuberculosis and Yersinia pestis under iron-poor in vitro conditions. [Full text]

04/13/2005  Governor, Majority Leader and Speaker Announce $2 Million in Biotech Research Awards: Targeted funding will help attract, retain promising early career scientists (NYSTAR)

Governor George E. Pataki, Senate Majority Leader Joseph L. Bruno and Assembly Speaker Sheldon Silver announced $2 million in [James D. Watson Investigator Program] awards designed to recognize and support outstanding scientists and engineers who, early in their careers, show potential for leadership and scientific discovery in the field of biotechnology. [Full text (PDF) | Excerpt | Awardees]

01/04/2005  NIH Initiatives Target Chemistry: New road-map-related initiatives show agency values role of chemistry in biomedical research (Chemical & Engineering News)

Graduate student Shiying Shang and postdoctoral fellow Jae-Sang Ryu work on developing diversity-oriented syntheses of libraries in the lab of Tan--work that fits nicely into a new road-map-related initiative. [Full text (membership req'd) | Full text (PDF)]

08/10/2004  Tireless Hunter of Cures and Kids (New York Post)

Derek Tan, a 31-year-old organic chemist who has been part of the campaign to help missing children since he was a teenager, lives by a simple formula. "It comes back to trying to address people issues," said Tan, who heads a research lab at Memorial Sloan-Kettering Cancer Center and also serves as an advisory board member to the Manhattan office of the National Center for Missing & Exploited Children. [Excerpt | Full text (PDF)]

Bookmark and SharePrintEmail This Page